Atara Biotherapeutics (ATRA) Dividend Stock History



Maximizing Profits: When is the Right Time to Sell Your Business?

April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?

Selling a business can be a momentous decision filled with many considerations and uncertainties. As an entrepreneur, this also symbolizes your years of…
Improve Your Financial Status: A How-To Guide

April 12, 2024 Improve Your Financial Status: A How-To Guide

Navigating through the complexities of personal finance can often feel like walking through a maze blindfolded. This guide is crafted especially for you,…
How ZIM Integrated Container Tracking is Revolutionizing Global Trade

April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade

Have you ever wondered how your online shopping packages get to you? A big part of the answer is ZIM Integrated Container Tracking.…
6 Best Growth Stocks To Buy Now According to Metatrader 5

March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5

One of the reasons investors prefer growth stocks is that they are expected to perform better than other companies in terms of sales…

Atara Biotherapeutics (ATRA) dividend


When will Atara Biotherapeutics pay the next dividends?

The date of payment of the next dividends from the Atara Biotherapeutics is scheduled for N/A.

If you see an old date, it means that the company has not yet approved a new dividend payout date. As soon as they do, we will update the information immediately. Bookmark our site to stay informed.

Atara Biotherapeutics dividend per share:

Dividends are paid at $ None per share.

Atara Biotherapeutics dividend history:

Previous date of dividend payment: N/A.

Splitting upAtara Biotherapeutics shares:

N/A

No information concerning Atara Biotherapeutics splitting shares.

Last Split Factor: N/A

Atara Biotherapeutics stock forecast.

What will happen to Atara Biotherapeutics stock? Atara Biotherapeutics shares will rise or fall. Visit the prediction section of our website to get an answer to this question.




Sell or Buy Atara Biotherapeutics (ATRA) stocks? Analytic Experts Forecasting...

We present you the most up-to-date and complete review of analytical trend forecasts and views on the ATRA stock market. Experts share their opinions on what to expect.

Atara Biotherapeutics stock chart in real time



A real-time chart of the Atara Biotherapeutics stock price is shown below. By default, the chart is set to the daily timeframe, but you can change it to the one that interests you. You can also use indicators on the chart.






Atara Biotherapeutics information and performance

Atara Biotherapeutics Address

611 GATEWAY BLVD, SUITE 900, SOUTH SAN FRANCISCO, CA, US

Market Capitalization: 82 358 000 $

Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.

EBITDA: -264 447 008 $

EBITDA is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: 0

Price/earnings to growth

DPS: None

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: None

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -2.61

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: 0

Quarterly Revenue Growth YOY: 13.46

Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: -

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 10.77

Enterprise Value (EV) /Revenue

EV To EBITDA: -0.347

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 119359000

Number of issued ordinary shares

Shares Float:

Number of freely tradable shares

Shares Short Prior Month:

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio:

Percent Insiders:

Percent Institutions: